NATCO Pharma Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
12.27 | 45.74 | -73.17% | 32.66 | -62.42% |
| P/S |
|
4.28 | 5.12 | -16.42% |
|
|
| P/BV |
|
2.91 | 6.3 | -53.8% |
|
|
| P/FCF |
|
16.15 | 168.72 | -90.43% |
|
|
| Ev/Ebitda |
|
9.66 | 13.54 | -28.64% |
|
|
| Ev/S |
|
4.36 | 4.77 | -8.55% |
|
|
| Ev/FCF |
|
20.34 | 163.7 | -87.58% |
|
|
| E/P |
|
0.1008 | 0.0451 | 123.44% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
26.14 | 20.29 | 28.87% | 32.29 | -19.03% |
| ROE |
|
25.88 | 17.11 | 51.25% |
|
|
| ROA |
|
22.1 | 10.34 | 113.83% |
|
|
| ROIC |
|
0 | 10.89 | -100% |
|
|
| ROS |
|
34.89 | 11.98 | 191.2% |
|
|
| ROCE |
|
13.84 | 4.26 | 224.57% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.1605 | 1.22 | -86.82% | 0.1606 | -0.0064% |
| Nеt Debt/Ebitda |
|
0.2958 | 1.06 | -72.05% |
|
|
| Debt/Ratio |
|
0.0242 | 0.1307 | -81.5% |
|
|
| Debt/Equity |
|
0.0725 | 0.5488 | -86.79% |
|
|
| Debt/Net Income |
|
0.1203 | 3.19 | -96.23% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
1.88/10
|
0.7538 | 11.92 | -93.68% | 1 | -24.67% |
| Number of years of dividend growth |
|
2 | 1.26 | 58.54% | ||
| DSI |
|
0.8571 | 0.8503 | 0.8034% |
|
|
| Average dividend growth |
|
-2.74 | -63.65 | -95.7% |
|
|
| Average percentage for 5 years |
|
1 | 11.6 | -91.37% |
|
|
| Average percentage for payments |
|
24.68 | 30.57 | -19.27% |
|
|
| Difference from average difference in sector |
|
-11.17 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
110.76 | 80.84 | 37.01% | ||
| Growth impulse Ebitda in 5 years |
|
12.83 | 45.31 | -71.68% | ||
| Growth impulse Net Income in 5 years |
|
201.28 | 131.41 | 53.17% | ||
| Growth impulse FCF in 5 years |
|
1352.98 | 76.02 | 1679.77% | ||
| Growth impulse EPS in 5 years |
|
206.73 | 286.48 | -27.84% |
IP Score
6.92/10
